Earl Blumenauer bought Sanofi ADR (NASDAQ: SNY)
Earl Blumenauer (D-OR), a U.S. Representative, has disclosed 1 trade in Sanofi ADR (SNY) since 2022, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Earl Blumenauer bought $15,001 - $50,000 of Sanofi ADR (NASDAQ: SNY) on May 27, 2022. Since that trade, SNY is down -7.14% against the S&P 500 up +88.75%, an outperformance of -95.90%.
Data updated
Earl Blumenauer's SNY trades vs the price
SNY is down -7.14% since Earl Blumenauer bought on May 27, 2022, versus +88.75% for the S&P 500.
Performance since this trade
All Earl Blumenauer SNY trades
Earl Blumenauer & SNY trading FAQ
Is it legal for Earl Blumenauer to trade Sanofi ADR (SNY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Sanofi ADR (SNY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Earl Blumenauer buy SNY?
Earl Blumenauer disclosed a purchase of $15,001 - $50,000 of Sanofi ADR (SNY) on May 27, 2022, according to public STOCK Act filings.
How has SNY performed since Earl Blumenauer's trade?
Since Earl Blumenauer bought SNY on May 27, 2022, the stock is down -7.14%, versus +88.75% for the S&P 500 over the same period, an outperformance of -95.90%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SNY trades?
Quantellect tracks every disclosed congressional trade in Sanofi ADR (SNY) on the Sanofi ADR congressional trading page, which aggregates filings across all members of Congress.
Earl Blumenauer's SNY tradesAll congressional filings for Sanofi ADREarl Blumenauer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.